Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (Text with EEA relevance) (c. 470)

TITLE II U.K. MAXIMUM RESIDUE LIMITS

CHAPTER I U.K. Risk assessment and risk management

Section 1 U.K. Pharmacologically active substances intended for use in veterinary medicinal products in the Community

Article 5 U.K. Extrapolation

With a view to ensuring the availability of authorised veterinary medicinal products for conditions affecting food-producing animals [F1 whilst ensuring a high level of protection of human health, the Secretary of State must consider extrapolating maximum residue limits from one species to another or from one foodstuff to another when drafting risk management recommendations]

Textual Amendments

F1 Words in Art. 5 substituted (31.12.2020) by The Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/676), regs. 1(2)(b), 6(6) (as amended by S.I. 2020/1461, regs. 1(2)(a), 3(4)(d)); 2020 c. 1, Sch. 5 para. 1(1)